Weiss Multi-Strategy Advisers’s Achillion Pharmaceuticals ACHN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,848,261	Closed	-$17.2M	–	716
2019 Q4	$17.2M	Buy	+2,848,261	New	+$16.5M	0.28%	107
2015 Q2	–	Sell	-14,000	Closed	-$138K	–	565
2015 Q1	$138K	Sell	14,000 -1,000	-7%	-$12.5K	0.01%	411
2014 Q4	$184K	Sell	15,000 -10,000	-40%	-$122K	0.01%	380
2014 Q3	$250K	Hold	25,000	–	–	0.01%	485
2014 Q2	$189K	Hold	25,000	–	–	﹤0.01%	694
2014 Q1	$82K	Sell	25,000 -90,436	-78%	-$317K	﹤0.01%	938
2013 Q4	$383K	Buy	+115,436	New	+$335K	0.01%	715
2013 Q3	–	Sell	-110,000	Closed	-$754K	–	1040
2013 Q2	$900K	Buy	+110,000	New	+$840K	0.03%	402

Weiss Multi-Strategy Advisers's ACHN Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 2,848,261 shares — an estimated $17.2M sold.

Weiss Multi-Strategy Advisers first reported a position in ACHN in Q2 2013 and held it in 8 quarters. The position peaked at $17.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Weiss Multi-Strategy Advisers reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 2,848,261 Achillion Pharmaceuticals shares in Q1 2020, an estimated $17.2M.
Weiss Multi-Strategy Advisers first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Achillion Pharmaceuticals position peaked at $17.2M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.